We look forward to the Sequire Investor Summit and the opportunity to meet with investors and update them on our novel targeted drug delivery platform as well as our lead product candidate APTN-101 ...

The 16,000-teu dual-fuel methanol Alexandra Maersk (built 2024) is the fifth ship in a series of 18 vessels scheduled for ...

The third day of the J.P. Morgan Healthcare Conference has begun, marking the last full slate of conference sessions and ...

Vojislav Gligorovski is one of only six recipients of the global International Birnstiel Award for Doctoral Research in ...

The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.

Liver failure is one of the most serious and deadly medical conditions, claiming thousands of lives each year as patients in ...

From fiber-based cosmetic packaging to recyclable fungi, these companies hope to advance the beauty industry’s sustainability ...

LG CNS is accelerating its digital health care business in partnership with CHA Biomedical Group, making a 10 billion won ($6 ...

The Chan Zuckerberg Biohub Chicago initiative is revolutionizing biomedical research with the help of artificial technologies ...

Alchemco enters 2026 with new COO, global sales lead, and special projects head to drive operations, growth, and ...

Researchers at The Grainger College of Engineering are developing biohybrid robots, mimicking muscles to better understand ...

Detailed price information for Intelligent Bio Solutions Inc (INBS-Q) from The Globe and Mail including charting and trades.